Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.35 CAD | +0.10% |
|
-1.26% | +17.96% |
06-25 | Parkland Shareholders Approve $9.1 Billion Acquisition by Sunoco | MT |
06-24 | Parkland shareholders vote for $9.1 billion acquisition by Sunoco | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.07 | 4.19 | 4.24 | 4.55 | 3.45 | |||||
Return on Total Capital | 4.34 | 6.04 | 6.12 | 6.55 | 4.98 | |||||
Return On Equity % | 4.9 | 5.48 | 12.89 | 15.15 | 4 | |||||
Return on Common Equity | 4.23 | 4.99 | 12.38 | 15.15 | 4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 16.67 | 13.77 | 11.34 | 12.23 | 12.63 | |||||
SG&A Margin | 9.4 | 7.1 | 5.72 | 6.78 | 7.09 | |||||
EBITDA Margin % | 6.32 | 5.37 | 4.02 | 4.89 | 4.54 | |||||
EBITA Margin % | 4.02 | 3.81 | 2.97 | 3.69 | 3.27 | |||||
EBIT Margin % | 3.22 | 3.22 | 2.47 | 3.16 | 2.72 | |||||
Income From Continuing Operations Margin % | 0.8 | 0.59 | 0.98 | 1.45 | 0.45 | |||||
Net Income Margin % | 0.59 | 0.45 | 0.87 | 1.45 | 0.45 | |||||
Net Avail. For Common Margin % | 0.59 | 0.45 | 0.87 | 1.45 | 0.45 | |||||
Normalized Net Income Margin | 0.7 | 0.62 | 0.83 | 1.15 | 0.61 | |||||
Levered Free Cash Flow Margin | 4.38 | 0.56 | 1.51 | 2.37 | 1.23 | |||||
Unlevered Free Cash Flow Margin | 5.42 | 1.21 | 2.03 | 3.04 | 1.99 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.52 | 2.08 | 2.74 | 2.31 | 2.03 | |||||
Fixed Assets Turnover | 3.71 | 5.21 | 7.41 | 6.28 | 5.54 | |||||
Receivables Turnover (Average Receivables) | 18.63 | 25.04 | 26.52 | 22.03 | 22.33 | |||||
Inventory Turnover (Average Inventory) | 16.33 | 19.09 | 20.89 | 16.26 | 15.13 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.16 | 1.39 | 1.39 | 1.29 | 1.32 | |||||
Quick Ratio | 0.67 | 0.75 | 0.77 | 0.62 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.4 | 0.4 | 0.53 | 0.45 | |||||
Days Sales Outstanding (Average Receivables) | 19.64 | 14.58 | 13.76 | 16.57 | 16.39 | |||||
Days Outstanding Inventory (Average Inventory) | 22.41 | 19.12 | 17.47 | 22.44 | 24.19 | |||||
Average Days Payable Outstanding | 40.74 | 30.21 | 27.19 | 36.09 | 40.69 | |||||
Cash Conversion Cycle (Average Days) | 1.32 | 3.49 | 4.04 | 2.92 | -0.1 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 183.76 | 238.25 | 229.57 | 199.87 | 209.76 | |||||
Total Debt / Total Capital | 64.76 | 70.44 | 69.66 | 66.65 | 67.72 | |||||
LT Debt/Equity | 170.39 | 232.93 | 223.87 | 193.87 | 201.52 | |||||
Long-Term Debt / Total Capital | 60.05 | 68.86 | 67.93 | 64.65 | 65.06 | |||||
Total Liabilities / Total Assets | 75.08 | 79.81 | 78.74 | 77.06 | 77.46 | |||||
EBIT / Interest Expense | 1.94 | 3.1 | 2.97 | 2.91 | 2.23 | |||||
EBITDA / Interest Expense | 4.51 | 5.83 | 5.44 | 5.2 | 4.56 | |||||
(EBITDA - Capex) / Interest Expense | 3.03 | 4.05 | 3.73 | 3.83 | 2.9 | |||||
Total Debt / EBITDA | 3.97 | 4.27 | 4.35 | 3.47 | 4.22 | |||||
Net Debt / EBITDA | 3.72 | 4.06 | 3.94 | 3.26 | 3.97 | |||||
Total Debt / (EBITDA - Capex) | 5.91 | 6.15 | 6.33 | 4.72 | 6.65 | |||||
Net Debt / (EBITDA - Capex) | 5.53 | 5.83 | 5.74 | 4.43 | 6.26 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -24.07 | 53.22 | 65.19 | -8.49 | -12.79 | |||||
Gross Profit, 1 Yr. Growth % | -17.63 | 26.54 | 36.03 | -1.32 | -6.83 | |||||
EBITDA, 1 Yr. Growth % | -25.13 | 38.42 | 23.76 | 11.28 | -19.08 | |||||
EBITA, 1 Yr. Growth % | -35.8 | 59.88 | 28.76 | 13.78 | -22.64 | |||||
EBIT, 1 Yr. Growth % | -40.66 | 73.43 | 26.59 | 16.89 | -24.71 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -72.95 | 12.5 | 174.6 | 36.13 | -73.04 | |||||
Net Income, 1 Yr. Growth % | -78.53 | 18.29 | 219.59 | 51.94 | -73.04 | |||||
Normalized Net Income, 1 Yr. Growth % | -72.69 | 98.69 | 104.42 | 29.33 | -52.91 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -78.82 | 18.52 | 200 | 36.98 | -72.62 | |||||
Accounts Receivable, 1 Yr. Growth % | -31.77 | 81.15 | 41.99 | -12.24 | -15.9 | |||||
Inventory, 1 Yr. Growth % | -16.67 | 87.69 | 37.94 | 0.74 | -14.05 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.57 | 16.37 | 16.08 | 0.91 | -3.01 | |||||
Total Assets, 1 Yr. Growth % | -2.04 | 27.01 | 23.71 | -2.95 | 1.28 | |||||
Tangible Book Value, 1 Yr. Growth % | 9.29 | 45.86 | -38.5 | -47.26 | -2.6 | |||||
Common Equity, 1 Yr. Growth % | -1.99 | 2.66 | 54.16 | 4.74 | -0.47 | |||||
Cash From Operations, 1 Yr. Growth % | 4.12 | -22.74 | 46.68 | 34.24 | -13.76 | |||||
Capital Expenditures, 1 Yr. Growth % | -29.45 | 12.18 | 27.02 | -4.18 | 19.29 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 140.73 | -78.99 | 344.64 | 28.62 | -54.79 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 91.64 | -63.83 | 176.88 | 26.42 | -43.03 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.71 | 1.68 | 4.69 | 5.5 | 2.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.5 | 7.86 | 59.09 | 22.95 | -10.66 | |||||
Gross Profit, 2 Yr. CAGR % | 7.62 | 2.09 | 31.2 | 15.86 | -5.72 | |||||
EBITDA, 2 Yr. CAGR % | -0.06 | -1.11 | 30.88 | 17.36 | -5.11 | |||||
EBITA, 2 Yr. CAGR % | -7.92 | -3.32 | 43.48 | 21.04 | -6.18 | |||||
EBIT, 2 Yr. CAGR % | -12.64 | -4.39 | 48.17 | 21.65 | -6.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -26.26 | -44.83 | 75.76 | 93.34 | -39.42 | |||||
Net Income, 2 Yr. CAGR % | -36.91 | -49.61 | 94.43 | 120.36 | -35.99 | |||||
Normalized Net Income, 2 Yr. CAGR % | -35.21 | -39.18 | 109.9 | 61.04 | -22.88 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -40.59 | -49.9 | 88.56 | 102.72 | -38.76 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.89 | 11.18 | 60.38 | 11.63 | -14.09 | |||||
Inventory, 2 Yr. CAGR % | 29.27 | 27.35 | 60.9 | 17.89 | -6.95 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 29.57 | 8.72 | 16.22 | 8.23 | -1.07 | |||||
Total Assets, 2 Yr. CAGR % | 26.74 | 11.54 | 25.35 | 9.57 | -0.86 | |||||
Tangible Book Value, 2 Yr. CAGR % | 102.51 | 26.26 | -5.29 | -43.05 | -28.33 | |||||
Common Equity, 2 Yr. CAGR % | 3.22 | 0.31 | 25.8 | 27.07 | 2.1 | |||||
Cash From Operations, 2 Yr. CAGR % | 42.34 | 0.39 | 6.46 | 40.32 | 7.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | 10.02 | -10.01 | 19.37 | 10.33 | 6.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 74.35 | -31.48 | -3.35 | 152.85 | -23.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 63.94 | -19.16 | 0.08 | 95.12 | -15.13 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.72 | 1.7 | 3.18 | 5.09 | 4.21 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.59 | 14.13 | 24.33 | 32.31 | 9.65 | |||||
Gross Profit, 3 Yr. CAGR % | 29.33 | 13.59 | 12.34 | 19.32 | 6.53 | |||||
EBITDA, 3 Yr. CAGR % | 29.98 | 9.18 | 6.57 | 23.99 | 3.68 | |||||
EBITA, 3 Yr. CAGR % | 24.46 | 7.16 | 6.37 | 32.81 | 4.26 | |||||
EBIT, 3 Yr. CAGR % | 23.23 | 5.4 | 4.99 | 36.91 | 3.67 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.95 | -15.11 | -5.81 | 61.41 | 0.26 | |||||
Net Income, 3 Yr. CAGR % | 0 | -22.2 | -6.72 | 79.09 | 9.4 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.65 | -17.16 | -6.4 | 77.46 | 6.05 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -7.85 | -25.21 | -9.03 | 69.51 | 4 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.21 | 28.24 | 20.62 | 31.18 | 1.57 | |||||
Inventory, 3 Yr. CAGR % | 17.76 | 48.15 | 30.79 | 37.65 | 6.1 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.73 | 25.01 | 11.12 | 10.88 | 4.35 | |||||
Total Assets, 3 Yr. CAGR % | 18.89 | 26.83 | 15.46 | 15.1 | 6.73 | |||||
Tangible Book Value, 3 Yr. CAGR % | 44.71 | 81.53 | -0.66 | -22.08 | -31.89 | |||||
Common Equity, 3 Yr. CAGR % | 5.27 | 3.03 | 15.76 | 18.35 | 17.13 | |||||
Cash From Operations, 3 Yr. CAGR % | 52.76 | 25.17 | 13.92 | 15.01 | 19.3 | |||||
Capital Expenditures, 3 Yr. CAGR % | 52.64 | 11.59 | 0.95 | 10.94 | 13.24 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 18.76 | -15.87 | 27.8 | 10.34 | 42.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.93 | -2.78 | 21.85 | 11.26 | 29.45 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.71 | 1.71 | 2.69 | 3.94 | 4.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.34 | 27.93 | 29.98 | 17.58 | 8.93 | |||||
Gross Profit, 5 Yr. CAGR % | 30.11 | 32.76 | 30.07 | 14.49 | 4.73 | |||||
EBITDA, 5 Yr. CAGR % | 33.63 | 36.63 | 28.77 | 12.38 | 1.74 | |||||
EBITA, 5 Yr. CAGR % | 31.81 | 36.68 | 29.22 | 12.51 | 1.16 | |||||
EBIT, 5 Yr. CAGR % | 31.66 | 37.89 | 29.45 | 11.62 | 0.37 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 23.18 | 21.7 | 33.37 | 17.99 | -21.05 | |||||
Net Income, 5 Yr. CAGR % | 15.73 | 15.5 | 30.47 | 17.99 | -19.77 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.02 | 16.19 | 25.08 | 9.84 | -13.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.71 | 5.49 | 22.71 | 11.44 | -22.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.01 | 27.88 | 23.82 | 21.32 | 5.31 | |||||
Inventory, 5 Yr. CAGR % | 40.82 | 50.34 | 34.39 | 35.21 | 14.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 51.91 | 51.55 | 19.5 | 18.01 | 6.07 | |||||
Total Assets, 5 Yr. CAGR % | 37.97 | 35.15 | 21.43 | 19.62 | 8.63 | |||||
Tangible Book Value, 5 Yr. CAGR % | 62.25 | 100.84 | 22.14 | 14.18 | -12.82 | |||||
Common Equity, 5 Yr. CAGR % | 18.75 | 19.63 | 13.05 | 12.05 | 10.09 | |||||
Cash From Operations, 5 Yr. CAGR % | 33.12 | 40.47 | 38.31 | 31.02 | 11.34 | |||||
Capital Expenditures, 5 Yr. CAGR % | 36.43 | 33.13 | 38.98 | 11.08 | 3.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 21.6 | -8.99 | 7.85 | 30.65 | 6.3 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 24.91 | 8.69 | 11.41 | 28.47 | 7.23 | |||||
Dividend Per Share, 5 Yr. CAGR % | 2.38 | 1.82 | 2.29 | 3.05 | 3.29 |
- Stock Market
- Equities
- PKI Stock
- Financials Parkland Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition